UCP of Central Arizona is the world’s first therapy clinic to offer the “Baby G,” Early Mobilization System, designed for ...
The study did not meet its primary endpoint of chorea improvement or key secondary endpoints at the time of analysis. Topline data were announced from a phase 3 trial evaluating valbenazine in ...
SAN DIEGO, Dec. 22, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy, safety, and tolerability of valbenazine ...
A review in Developmental Medicine & Child Neurology summarizes the multiple benefits of sport participation for people with cerebral palsy. The authors present a summary of available sports, as well ...